BD launches portable rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The launch of this new assay that delivers results in 15 minutes on an
